There is so much to keep track of when it comes to diabetes medication updates and additions. That’s why Coach Beverly and Bryanna are scouring articles and announcements to keep our Medication PocketCards relevant and up-to-date for our community.
We update our downloadable electronic PocketCards on our CDCES Coach app and website each time we announce a medication update.
Laminated PocketCards are updated and ready to be delivered to you!
Purchase yours today and take advantage of our quantity discounts! Great holiday gift!
Since our last announcement, there have been three changes.
The GLP-1 RA, dulaglutide, (Trulicity), has two new higher doses. Until now, the approved doses for Trulicity were 0.75mg and 1.5 mg. The expanded dosing will include a 3.0 mg and 4.5 mg weekly Trulicity dose. Based on recent research, by increasing the dose to 4.5 mgs participants experienced an average weight loss of 10.4 pounds and a 1.9% drop in A1c. Of course, the increased dose is associated with nausea and GI upset, so a gradual titration up to this higher dose should be considered.
There is a new biosimilar basal insulin called Semglee.
One of our scholarship recipients, Mercy Edziah, alerted us to the addition of yet another biosimilar glargine insulin. Semglee is available in a 10 mL vial or 3mL prefilled pens. This new insulin is competitively priced. Semglee is listed at $98.65 per 10mL vial and $147.98 for a box of five pens.
Thank you to Mercy and our community, for sharing news with us so we can pass it along to others.
Canagliflozin (Invokana) removed the black box warning. Previously, the FDA had announced in 2017 that people on canagliflozin, an SGLT-2 Inhibitor, had an increased risk of lower extremity amputation. In August 2020, the FDA removed that black box warning.
Safety information from recent clinical trials suggests that the risk of amputation, while still increased with canagliflozin, is lower than previously described, particularly when appropriately monitored. Therefore, the FDA concluded that the Boxed Warning should be removed
Canagliflozin and 2 of the other of the SGLT-2 Inhibitors, dapagliflozin and Empagliflozin, have demonstrated additional heart- and kidney-related benefits. They are FDA approved to reduce the risk of major heart-related events such as heart attack, stroke, or death in people with type 2 diabetes who have known heart disease. They are also approved to reduce the risk of end-stage kidney disease, worsening of kidney function, and heart failure in certain people with type 2 diabetes and diabetic kidney disease.
We hope you find these Pocketcards as an easy-to-use resource that is helpful in your clinical practice and exam preparation.
Are you interested in learning about diabetes care for the frail and elderly? Then consider attending this all-day conference that synthesizes exciting findings and new elements that you can incorporate into your daily practice. Through dynamic presentations and case studies, we will provide you with creative strategies to take your practice to the next level. In addition, small group activities allow participants to network and share problem-solving strategies. The goal of this program is to provide cutting edge information that has real-life application. We want each participant to leave the seminar feeling more empowered and confident advocating for excellence in diabetes care.
Registration Price:
$20 for ADCES members – $40 for non-ADCES members – 6.5 CEs
Click here to register. – Download flyer here.
Who Should Attend?
This course is designed for all health care professionals including providers, nurses, dietitians, pharmacists, and educators who want to:
Requirements for Successful Completion: Participants should try to be in attendance for all three webinars, complete and submit the program evaluation at the conclusion of each webinar. Partial CE hours (2.25 CE hours) can be awarded per webinar if participants complete and submit the program evaluation. The three webinars will be recorded for later viewing but NO CE hours will be awarded for viewing of the recorded webinars.
Registration Price:
$20 for ADCES members – $40 for non-ADCES members – 6.5 CEs
Click here to register. – Download flyer here.
Sign up for Diabetes Blog Bytes – we post one daily Blog Byte from Monday to Friday. And of course, Tuesday is our Question of the Week. It’s Informative and FREE! Sign up below!
Accreditation: Diabetes Education Services is an approved provider by the California Board of Registered Nursing, Provider 12640, and Commission on Dietetic Registration (CDR), Provider DI002. Since these programs are approved by the CDR it satisfies the CE requirements for the CDCES regardless of your profession.*
The use of DES products does not guarantee the successful passage of the CDCES exam. CBDCE does not endorse any preparatory or review materials for the CDCES exam, except for those published by CBDCE.
Meds Management PowerPoint Slides 2 per page
Meds Management PowerPoint Slides 1 per page
Please download Medication and Insulin PocketCards
Or Download FREE CDCES Coach App for easy PocketCard access
ADCES Insulin Cost Savings Resources Page.
Insulin Storage Cheat Sheet for all kinds of important details on storage and more!
Pharmacologic Approaches to Glycemic Treatment 2020. This hyperglycemia road map details strategies to achieve glucose control for both Type 1 and Type 2
Interested in achieving certification? Check out our Getting Started Page
Sign up for our Free DiabetesEd Newsletter here.
Thanks everyone for this opportunity! Beverly Thomassian
We know that a great resource page full of accurate and helpful cheat sheets can save busy diabetes specialists time and energy.
That’s why we have put together our entire list of cheat sheets so you can access them with ease.
These sheets and cards include information to study for certification exams and to use in your clinical setting. Plus, we have included teaching sheets for people with diabetes.
In each webinar, either Coach Beverly, Dr. Isaacs, or Ms. Armstrong, highlight the critical content of each topic area, so you can focus your study time most efficiently. They also launch multiple poll questions to help participants focus on key concepts and assess their knowledge while learning the best test-taking strategies.
2020 Boot Camp Live Stream Webinar Schedule with Coach Beverly
All courses air at 11:30 a.m. (PST)
Can’t make it live?
No worries! All video presentations and podcasts will be available now on-demand.
Sign up for Diabetes Blog Bytes – we post one daily Blog Byte from Monday to Friday. And of course, Tuesday is our Question of the Week. It’s Informative and FREE! Sign up below!
Accreditation: Diabetes Education Services is an approved provider by the California Board of Registered Nursing, Provider 12640, and Commission on Dietetic Registration (CDR), Provider DI002. Since these programs are approved by the CDR it satisfies the CE requirements for the CDCES regardless of your profession.*
The use of DES products does not guarantee the successful passage of the CDCES exam. CBDCE does not endorse any preparatory or review materials for the CDCES exam, except for those published by CBDCE.
For people with type 1 diabetes, access to Continuous Glucose Monitoring (CGM) technology, is considered a standard of care by most experts.
There is plenty of research that demonstrates CGM use is associated with not only improved A1c but significantly decreases time in hypoglycemic range and ketoacidosis rates.
YES.
According to a study presented at the Heart in Diabetes virtual meeting.
After three years of follow-up, the savings were substantial.
“In this study, we showed that it didn’t make any difference how you deliver insulin,” Grunberger said. “This difference is in how you monitor glucose.”
George Grunberger, MD, FACP, MACE, Chairman Grunberger Diabetes Institute and more
Glucose Crises are Expensive
According to Grunberger, the cost of diabetes ketoacidosis (DKA) in the U.S. is over 5 billion dollars a year.
Having a CGM reduces DKA rates, hospitalization, and leads to cost savings.
A study in the United Kingdom showed that for 900 people using the Freestyle Libre (Abbott), DKA episodes were reduced by 80% within six months of using this device.
A study in Belgium followed 1,913 people with type 1 diabetes using the Freestyle Libre CGM.
Not only did they see a dramatic reduction in hospitalizations from DKA and hypoglycemia, but the researchers also observed a fifty percent drop in work absenteeism.
Full Story: Healio (free registration)/Endocrine Today (8/31)
Sign up for Diabetes Blog Bytes – we post one daily Blog Byte from Monday to Friday. And of course, Tuesday is our Question of the Week. It’s Informative and FREE! Sign up below!
Accreditation: Diabetes Education Services is an approved provider by the California Board of Registered Nursing, Provider 12640, and Commission on Dietetic Registration (CDR), Provider DI002. Since these programs are approved by the CDR it satisfies the CE requirements for the CDCES regardless of your profession.*
The use of DES products does not guarantee the successful passage of the CDCES exam. CBDCE does not endorse any preparatory or review materials for the CDCES exam, except for those published by CBDCE.
Glucagon is a counter-regulatory hormone secreted by the pancreas when blood sugars are dipping or during periods of emotional or physical stress. This hormone liberates stored glycogen from the liver, causing an upward surge in circulating glucose.
When people become hypoglycemic, there is not enough circulating glucagon available to drive more glucose release. Glucagon rescue medications increase glucagon levels enough to stimulate further glucose release from glycogen stores in the body.
While administering glucagon is life saving, it also depletes the body of its glycogen reserves and can lead to further hypoglycemia if it is not replaced quickly. It is so important to replace glycogen stores by consuming carbohydrates as soon as it is safe.
When someone with diabetes is experiencing severe hypoglycemia and needs the assistance of another person, there are now 3 Glucagon options to choose from.
Here are some highlights of the currently available Glucagon Rescue Medications. Below, is our new Glucagon PocketCard that helps to compare and contrast the delivery system, dosing, age range, route and storage all in one card.
Baqsimi is a nasal glucagon powder to treat severe hypoglycemia in people with diabetes ages four and older. This non-injectable form of glucagon is available as one pack or 2 pack.
It is approved for pediatrics over the age of four with type 1 diabetes and adults.
Baqsimi does not need to be inhaled, which means it can be effectively administered to a person who is unconscious due to severe hypoglycemia.
*Eligible commercially insured people with diabetes can pay $25 for up to two BAQSIMI devices (1 two-pack or 2 one-packs) with a savings card. This prescription is generally filled on an annual basis. For more info visit www.BAQSIMI.com or call The Lilly Answers Center at 1-800-LillyRx (1-800-545-5979).
Xeris Pharmaceuticals offers a pre-filled liquid stable form of glucagon that is approved for use in people with diabetes, age 2 and older. They also have an HypoPen Auto-Injector.
The Xeris glucagon pen was created to simplify glucagon injections. This new Gvoke pen does not require any mixing since it is filled with liquid stable glucagon.
Gvoke Pre-Filled Syringe and HypoPen 2-PackTM is also available. Health care professionals can request a Gvoke HypoPen demo device by completing this request form or contacting your local sales representative. Read more about the Gvoke Glucagon Pen and auto-injector here.
Eligible commercially insured people with diabetes can pay as little at $0 by completing the Gvoke Copay Card* form. Visit this page to sign-up.
Both Lilly and NovoNordisk manufacture this injectable glucagon that requires mixing glucagon powder in a vial with a diluent, then injecting either sub-q or IM. It can be administered to all ages, but give a half dose for children weighing less than 45kg.
Glucagon rescue medications raise blood sugar by at least 20 mg/dl and should start working within 15 minutes.
When addressing severe hypoglycemia, fast and effective treatment is critical. Diabetes Specialists have a vital role in making sure those at risk of a hypoglycemic crisis have a glucagon rescue medication available.
Our new PocketCard provides a concise review of the 3 Glucagon Emergency treatment options.
This card can serve as a decision tool when discussing the pros and cons of the currently available rescue medications with providers and people living with diabetes.
Our new Glucagon PocketCard compares and contrasts the delivery system, dosing, age range, route, and storage of the currently available rescue meds all in one card.
Request a FREE Glucagon Pocket Card to be mailed to your door later this month.
We are offering a FREE copy of this laminated card to the first 50 requests (one per person please).
View it for FREE anytime our CDCES Coach App by clicking on the PocketCard Image on the home screen.
Download it FREE on our PocketCard Page.
Glucagon Rescue Medications require a prescription. Check expiration dates before using them. This information on the Glucagon PocketCard is for educational purposes only. Please consult package inserts for detailed instructions.
Hypoglycemia and Hyperglycemia Education Teaching Sheet » This handout is one of my favorites. Cartoon characters depict the signs and symptoms of low and high blood sugars and then detail steps to take.
Medication Wallet Card PDF » pocket sized document that includes contact info, list of medications and critical health data.
Medication Wallet Card in WORD » Add your program’s logo and provide your clients with a useful, customized document that includes contact info, list of medications and critical health data.
Sign up for Diabetes Blog Bytes – we post one daily Blog Byte from Monday to Friday. And of course, Tuesday is our Question of the Week. It’s Informative and FREE! Sign up below!
This newly FDA approved rapid-acting insulin analog is aimed at reducing post-meal glucose spikes.
Lyumjev also known as insulin lispro-aabc, is approved for adults with Type 1 or Type 2 diabetes, can be taken before meals or even 20 minutes into the meal.
Insulin lispro-aabc (Lyumjev) by Lilly is comparable to Fiasp by Novo Nordisk since they are both very rapid-acting insulins that are detectable in the circulation within minutes of injection.
Insulin lispro-aabc (Lyumjev) appears in circulation approximately 1 minute after injection, peaks at 57 minutes and has an effective duration of about four to five hours. The safety and effectiveness of pediatrics with diabetes has not been established.
Description:
Insulin lispro-aabc (Lyumjev) is produced by recombinant DNA technology using a non-pathogenic strain of E coli. Insulin lispro-aabc differs from human insulin due to a switching of lysine and proline in the B28 and B29 position. Its chemical name is Lys(B28), Pro(B29) human insulin analog. See the package insert for more information.
Pricing:
Insulin lispro-aabc (Lyumjev) will be offered at the same price as lispro (Humalog). Lilly will also offer Lyumjev at $35 per month for people who are uninsured or have commercial insurance through its Insulin Value Program. The $35 cap applies regardless of the number of insulin doses required.
How supplied:
Insulin lispro-aabc (Lyumjev) comes in two strengths: U-100 (100 units per milliliter) and U-200 (200 units per milliliter) and a variety of delivery options, including the Junior KwikPen® which allows for 0.5 unit dosing increments.
Lyumjev Injection: 100 units/mL (U-100) available as:
• 10 mL multiple-dose vial
– 3 mL 300 unit KwikPen® (5 pens)
• 3 mL 300 unit Junior KwikPen® 0.5 unit dose increment (5 pens)
• 3 mL 300 unit Tempo Pen™ (5 pens)
• 3 mL 300 unit cartridges (5 cartridges)
Lyumjev Injection: 200 units/mL (U-200) available as:
• 3 mL KwikPen® (2 pens with 600 units each)
Storage:
Discard opened or unopened insulin lispro-aabc (Lyumjev) vials, pens, and cartridges stored at room temperature below 86°F (30°C) after 28 days.
Stay tuned for more new insulin approvals and updates to our Insulin PocketCards!
Level 3 | Boot Camp + Expert Team Bundle
Join us live starting September 16th!
When you join our DiabetesEd Certification Boot Camp, it’s like having your own online coaching staff.
?In each webinar, either Coach Beverly, Dr. Isaacs, or Ms. Armstrong, highlight the critical content of each topic area, so you can focus your study time most efficiently. They also launch multiple poll questions to help participants focus on key concepts and assess their knowledge while learning the best test-taking strategies.
Mastery of this content is critical to ensure certification exam success and to improve clinical outcomes.
Click here to download Level 3 + Expert Bundle flyer Enroll Today!
Sign up for Diabetes Blog Bytes – we post one daily Blog Byte from Monday to Friday. And of course, Tuesday is our Question of the Week. It’s Informative and FREE! Sign up below!
Accreditation: Diabetes Education Services is an approved provider by the California Board of Registered Nursing, Provider 12640, and Commission on Dietetic Registration (CDR), Provider DI002. Since these programs are approved by the CDR it satisfies the CE requirements for the CDCES regardless of your profession.*
The use of DES products does not guarantee the successful passage of the CDCES exam. CBDCE does not endorse any preparatory or review materials for the CDCES exam, except for those published by CBDCE.
There are 3 glucagon rescue medications to choose from! Our two-sided Glucagon Pocketcard, designed by Coach Beverly Thomassian, is a perfect decision aid and teaching tool designed for sharing with colleagues and people with diabetes alike.
This card can serve as a decision tool when discussing the pros and cons of the currently available rescue medications with providers and people living with diabetes.
Plus, this card highlights prevention and treatment options for hypoglycemia. It is also an excellent study tool for certification exam preparation.
This Diabetes Glucagon PocketCard is perfect for all Diabetes Care and Education Specialists.
Get yours today!
View it for FREE anytime on our CDCES Coach App! Access by clicking on the PocketCard on our apps home screen.
Download Glucagon PocketCard for FREE on our PocketCard Page.
Glucagon Rescue Medications require a prescription. Check expiration dates before using them. This information on the Glucagon PocketCard is for educational purposes only. Please consult package inserts for detailed instructions.
Glucagon is a counter-regulatory hormone secreted by the pancreas when blood sugars are dipping or during periods of emotional or physical stress. This hormone liberates stored glycogen from the liver, causing an upward surge in circulating glucose.
When people become hypoglycemic, there is not enough circulating glucagon available to drive more glucose release. Glucagon rescue medications increase glucagon levels enough to stimulate further glucose release from glycogen stores in the body.
While administering glucagon is life-saving, it also depletes the body of its glycogen reserves and can lead to further hypoglycemia if it is not replaced quickly. It is so important to replace glycogen stores by consuming carbohydrates as soon as it is safe.
Glucagon rescue medications raise blood sugar by at least 20 mg/dl and should start working within 15 minutes.
Hypoglycemia and Hyperglycemia Education Teaching Sheet » This handout is one of my favorites. Cartoon characters depict the signs and symptoms of low and high blood sugars and then detail steps to take.
Medication Wallet Card PDF » pocket sized document that includes contact info, list of medications and critical health data.
Medication Wallet Card in WORD » Add your program’s logo and provide your clients with a useful, customized document that includes contact info, list of medications and critical health data.